Pharmaceutical Substances Syntheses, Patents, Applications - Part 145

Pharmaceutical Substances Syntheses, Patents, Applications - Part 145. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers | Nilutamide N 1441 rCH3 hn ch3 POCI3 ----------- phosphorus oxychloride nicotinic diethylamine acid Reference s DRP351 085 Ciba 1920 . DRP 441 707 Ciba 1924 . Formulation s drg. 50 mg in comb as calcium thiocyanate powder 150 mg sol. 250 mg ml Trade Name s D Felsol Roland -comb. Zellaforte Plus Eurim Pharma -comb. F Coramine Ciba wfm GB Coramine Ciba wfm 1 Miocardina Croce Bianca wfm J Coramin Ciba-Geigy- Takeda USA Coramine Ciba wfm Nilutamide RU-23908 ATC G03H L02BB02 Use non-steroidal antiandrogen for treatment of prostatic carcinoma RN 63612-50-0 MF Cl2H10F N3O4 MW LD50 200 mg kg M . 195 mg kg R . CN 5 5-dimethyl-3- 4-nitro-3- trifluoromethyl phenyl -2 4-imidazolidinedione y-trifluorometnyl-ocetanilide HNO3 H2SO4 ------------- no2 3- trtfluoromethyl- 4- nitroaniline U CI CI ----------- phosgene ch3 H3C j nh2 CN no2 1 - 3-trif luoromethyl- 4-nitrophenyl imino-2-imidazolidinone 2-amino-2-cyonopropone 3- trifluoromethyl- 4- nitrophenyl isocyanate I Reference s DOS 2 649 925 Roussel-Uclaf appl. F-prior. . US 4 097 578 Roussel-Uclaf F-prior. . synthesis q 3-trifluorornethyl-4-nitropheny isocyanate Rouche H. Bull. Cl. Sci. Acad. R. Belg. BCSAAF 13 346 1927 . JP6 725 067 Japan Bureau of Ind. Techn. appl. . 1442 N Nilvadipine medical use for the treatment of hormone dependent cancer other than pmstatic cancer WO 8 803 404 Roussel-Uclaf appl. I-prior. . Formulation s tabl. 50 mg Trade Name s F Anandron Cassenne USA Nilandron HoechstMarion Roussel Nilvadipine FR-34235 Niprodipine ATC C08CA10 Use calcium antagonist antihypertensive antianginal RN 75530-68-6 MF C19H19N3O6 MW LD5 I 9150 pg kg M . 1300 mg kg M . 9650 pg kg R . 1560 mg kg R . 3850 pg kg dog . 510 mg kg dog . CN 2-cyano-l 4-dihydro-6-methyl-4- 3-nitrophenyl -3 5-pyridinedicarboxylic acid 3-methyl 5- l-methylethyl ester 3-nitro- benzoldehyde CHjO isopropyl acetoocetote isopropyl 2- .

Không thể tạo bản xem trước, hãy bấm tải xuống
TÀI LIỆU MỚI ĐĂNG
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.